Business Context and Reporting Period
Company: Community Health Systems, Inc. (CHS)
Filing Type: Form 8-K (Current Report)
Report Date: February 2, 2021 (Earliest event reported: January 29, 2021)
Context: The filing details a significant capital restructuring involving the issuance of new debt to refinance existing obligations and the redemption of senior notes.
Key Financial Metrics and Debt Structure
- New Debt Issuance: Completed an offering of $1,775,000,000 aggregate principal amount of 6.875% Junior-Priority Secured Notes due 2029.
- Interest Terms: New notes bear interest at 6.875% per year, payable semi-annually starting October 15, 2021.
- Security Structure: Notes are secured by shared second-priority liens on Non-ABL Priority Collateral and shared third-priority liens on ABL Priority Collateral.
- Refinancing Activity:
- 2023 Notes: Intended to repurchase/redeem all outstanding Junior-Priority Secured Notes due 2023. As of the Early Tender Deadline, $132,925,000 (approx. 7.52%) was tendered. The remaining balance is to be redeemed at 107.406% of principal.
- 2022 Notes: Issued notice to redeem all outstanding 6.875% Senior Notes due 2022 on February 28, 2021, at 100.000% of principal.
Material Changes and Transactions
The primary material change is the entry into a Material Definitive Agreement (Indenture) and the creation of direct financial obligations to facilitate a debt refinancing strategy. The company is replacing maturing or callable debt (2022 and 2023 notes) with longer-term debt (2029 notes) to extend its maturity profile.
Use of Proceeds: Net proceeds from the $1.775 billion Notes Offering, combined with cash on hand, are designated to:
- Purchase 2023 Junior-Priority Secured Notes tendered in the cash tender offer.
- Redeem remaining 2023 Junior-Priority Secured Notes.
- Pay related fees and expenses.
Guidance, Covenants, and Risks
Redemption Provisions:
- Make-Whole: Prior to April 15, 2024, the Issuer may redeem notes at 100% principal plus accrued interest and a "make-whole" premium.
- Equity Redemption: Prior to April 15, 2024, up to 40% of the principal may be redeemed using proceeds from certain equity offerings.
- Change of Control: Triggers a mandatory repurchase offer at 101% of principal plus accrued interest.
Covenants: The Indenture restricts the Issuer's ability to incur additional indebtedness, pay dividends, make restricted payments, create liens, sell assets, or enter into merger transactions without satisfying specific conditions.
Risks: The filing notes customary events of default, including nonpayment, breach of agreements, and bankruptcy. The complex intercreditor agreements restrict the Collateral Agent's actions regarding the collateral.
Investor Verification Checklist
- Verify the final acceptance rate of the tender offer for the 2023 Junior-Priority Secured Notes to confirm the total cash outflow required for the refinancing.
- Confirm the exact redemption date and payment amount for the 2022 Senior Notes (scheduled for February 28, 2021).
- Review the full text of the Indenture (Exhibit 4.1) and Collateral Agreement (Exhibit 4.2) to understand specific limitations on future capital raising and dividend payments.
- Assess the impact of the new 6.875% interest rate on future interest expense compared to the refinanced debt.
- Monitor the company's liquidity position to ensure sufficient cash on hand exists to cover the redemption of the 2023 notes not tendered in the offer.